Chromosomal and biochemical studies on the effect of kat extract on laboratory rats.
Kat is being used extensively in many countries as a central nervous system stimulant. The effect of three doses of crude kat extract on chromosomal division and abnormalities in bone marrow, as well as on DNA, RNA, and total protein content in brain and liver was studied in laboratory rats in order to test the possible mutagenicity of the drug. Kat was given as a single subcutaneous injection at 0.05 (usage dose), 0.52 (intermediate dose), and 1.00 (sublethal dose) g/kg body weight. Animals were sacrificed at 6, 24, and 48 hr after treatment. Also, some animals were exposed subacutely for 5 consecutive days with sacrifice occurring 6 hr after the last injection. The mitotic index was reduced by all treatments, with the greatest effect occurring in the subacute treatment. Chromosomal abnormalities were induced by kat at all three doses, administered acutely or subacutely. The significant chromosomal aberrations were in the form of gaps, breaks, centromeric attenuations, and centric fusions. The concentration of DNA, RNA, and total protein in liver and brain decreased at all doses, with the greatest decrease occurring after subacute treatment. These findings suggest that kat has a profound effect on cell proliferation, on chromosomal abnormalities, and on DNA, RNA, and total protein synthesis.
D000470:Alkaloids / Q000633:toxicity*; D000818:Animals; D001853:Bone Marrow / Q000187:drug effects; D001921:Brain / Q000378:metabolism; D029754:Catha; D002869:Chromosome Aberrations; D008099:Liver / Q000378:metabolism; D008297:Male; D008938:Mitosis / Q000187:drug effects; D009696:Nucleic Acids / Q000378:metabolism; D010665:Phenylpropanolamine / Q000633:toxicity; D010936:Plant Extracts / Q000633:toxicity*; D011506:Proteins / Q000378:metabolism; D051381:Rats
D000470:Alkaloids; D009696:Nucleic Acids; D010936:Plant Extracts; D011506:Proteins; C005331:norpseudoephedrine; D010665:Phenylpropanolamine; C023665:cathinone; C043688:cathidine